Atovaquone Suspension
Product Images NDC 73141-104

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 73141-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A2a Integrated Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atovaquone Foil Label (A2a Atovaquone 05ml Foil Final 11 4 24 Jpg)

Atovaquone Foil Label (A2a   Atovaquone 05ml Foil Final 11 4 24 Jpg)
Atovaquone Oral Suspension, USP 750 mg/5 mL label for oral use, distributed by A2A Integrated Pharmaceuticals, LLC. The label includes storage instructions (59° to 86°F), a barcode, a note to shake gently before using, and indicates the product is for institutional use only and prescription use (Rx Only).*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Atovaquone showing its molecular framework with a chlorophenyl group attached to a hydroxy-1,4-naphthoquinone core.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.